US Congress House Bill 5775 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Republican 4-2)
Status: Engrossed on June 20 2018 - 50% progression, died in committee
Action: 2018-06-20 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]

PROPER Act of 2018 Providing Reliable Options for Patients and Educational Resources Act of 2018 (Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period). (Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs. (Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.

PROPER Act of 2018 Providing Reliable Options for Patients and Educational Resources Act of 2018

Rep. Erik Paulsen [R-MN]	Rep. Bruce Poliquin [R-ME]	Rep. Ron Kind [D-WI]	Rep. Conor Lamb [D-PA]
Rep. Brian Fitzpatrick [R-PA]	Rep. Sam Johnson [R-TX]

Date	Chamber	Action
2018-06-20	Senate	Received in the Senate and Read twice and referred to the Committee on Finance.
2018-06-19	House	Motion to reconsider laid on the table Agreed to without objection.
2018-06-19	House	On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)
2018-06-19	House	DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.
2018-06-19	House	Considered under suspension of the rules. (consideration: CR H5256-5258)
2018-06-19	House	Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.
2018-06-19	House	Placed on the Union Calendar, Calendar No. 594.
2018-06-19	House	Committee on Energy and Commerce discharged.
2018-06-19	House	Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
2018-06-04	House	Referred to the Subcommittee on Health.
2018-05-16	House	Ordered to be Reported (Amended) by Voice Vote.
2018-05-16	House	Committee Consideration and Mark-up Session Held.
2018-05-11	House	Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2018-05-11	House	Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2018-05-11	House	Introduced in House

HB5686 (Related) 2018-06-12 - Placed on the Union Calendar, Calendar No. 575.
HB5714 (Related) 2018-05-23 - Referred to the Subcommittee on Health.
HB5719 (Related) 2018-05-22 - Referred to the Subcommittee on Health.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
SB3489 (Related) 2018-09-25 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/house-bill/5775/all-info
Text	https://www.congress.gov/115/bills/hr5775/BILLS-115hr5775ih.pdf
Text	https://www.congress.gov/115/bills/hr5775/BILLS-115hr5775rh.pdf
Text	https://www.congress.gov/115/bills/hr5775/BILLS-115hr5775eh.pdf